Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk

Abstract

ClinicalTrials.gov Identifier: NCT01897532.

Keywords

Affiliated Institutions

• University of Würzburg DE
• Universität Ulm DE
• The George Institute for Global Health AU
• Clinical Research Institute US
• Lunenfeld-Tanenbaum Research Institute CA
• VA Puget Sound Health Care System US
• Boehringer Ingelheim (Netherlands) NL
• Universitätsklinikum Aachen DE
• Boehringer Ingelheim (Norway)
• Monash University AU
• Dallas Diabetes Research Center US
• Boehringer Ingelheim (Germany) DE
• University of Toronto CA
• The University of Texas Southwestern Medical Center US
• Mount Sinai Hospital CA
• University of Washington US
• UNSW Sydney AU
• RWTH Aachen University DE

Related Publications